Medlab Clinical Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 14
Employees
  • Stock Symbol
  • MDC
Stock Symbol
  • Share Price
  • $0.21
  • (As of Friday Closing)

Medlab Clinical General Information

Description

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
ASX
Primary Office
  • Unit 5-6/11 Lord Street
  • Botany
  • Sydney, New South Wales 2019
  • Australia
+61 (02) 0000 0000

Medlab Clinical Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medlab Clinical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.21 $0.22 $0.07 - $0.27 $57.6M 280M 287K

Medlab Clinical Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 29,894 23,025 38,956 72,426
Revenue 1,908 3,884 3,206
EBITDA (8,309) (5,923) (3,683)
Net Income (8,974) (5,785) (3,540)
Total Assets 12,223 14,150 17,870
Total Debt 1,604 720 367
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medlab Clinical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medlab Clinical‘s full profile, request access.

Request a free trial

Medlab Clinical Executive Team (3)

Name Title Board Seat Contact Info
Sean Hall Chief Executive Officer & Managing Director
Alan Dworkin Chief Financial Officer & Company Secretary
Ian Curtinsmith Chief Information Officer
To view Medlab Clinical’s complete executive team members history, request access »

Medlab Clinical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial